Heart attack drug may prevent dangerous 'No-Reflow' during artery opening
NCT ID NCT07536802
First seen Apr 30, 2026 · Last updated May 24, 2026 · Updated 4 times
Summary
This study tests whether giving the drug adenosine before angioplasty (a procedure to open blocked heart arteries) can reduce the risk of slow or no blood flow afterward in people having a heart attack. About 1,148 adults with a specific type of heart attack (STEMI) will take part. The goal is to see if this simple pre-treatment improves blood flow and heart outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYOCARDIAL INFARCTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
National Institute of Cardiovascular Diseases
RECRUITINGKarachi, Sindh, 75510, Pakistan
-
National Institute of Cardiovascular Diseases
RECRUITINGKarachi, Sindh, 75510, Pakistan
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.